Cargando…

Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar

Accurate determination of mortality attributable to SARS-CoV-2 vaccination is critical in allaying concerns about their safety. We reviewed every death in Qatar that occurred within 30 days of any SARS-CoV-2 vaccine administration between January 1, 2021 and June 12, 2022. Probability of association...

Descripción completa

Detalles Bibliográficos
Autores principales: Butt, Adeel A., Guerrero, Mylai D., Canlas, Elenor B., Al-Dwairi, Husni, Alimam, Abeir Bakhiet Mohammed Ali, Mohamad, Abdur Rehman, Ali, Mohammed Thamer, Asaad, Nidal Ahmad, Alkeldi, Ali Ahmed Sheikh Saleh, Mohammad, Mohammad Fawaz Saber, Thomas, Anil G., Al-Khal, Abdullatif, Al-Maslamani, Muna, Abou-Samra, Abdul-Badi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808756/
https://www.ncbi.nlm.nih.gov/pubmed/36596793
http://dx.doi.org/10.1038/s41467-022-35653-z
_version_ 1784862999872274432
author Butt, Adeel A.
Guerrero, Mylai D.
Canlas, Elenor B.
Al-Dwairi, Husni
Alimam, Abeir Bakhiet Mohammed Ali
Mohamad, Abdur Rehman
Ali, Mohammed Thamer
Asaad, Nidal Ahmad
Alkeldi, Ali Ahmed Sheikh Saleh
Mohammad, Mohammad Fawaz Saber
Thomas, Anil G.
Al-Khal, Abdullatif
Al-Maslamani, Muna
Abou-Samra, Abdul-Badi
author_facet Butt, Adeel A.
Guerrero, Mylai D.
Canlas, Elenor B.
Al-Dwairi, Husni
Alimam, Abeir Bakhiet Mohammed Ali
Mohamad, Abdur Rehman
Ali, Mohammed Thamer
Asaad, Nidal Ahmad
Alkeldi, Ali Ahmed Sheikh Saleh
Mohammad, Mohammad Fawaz Saber
Thomas, Anil G.
Al-Khal, Abdullatif
Al-Maslamani, Muna
Abou-Samra, Abdul-Badi
author_sort Butt, Adeel A.
collection PubMed
description Accurate determination of mortality attributable to SARS-CoV-2 vaccination is critical in allaying concerns about their safety. We reviewed every death in Qatar that occurred within 30 days of any SARS-CoV-2 vaccine administration between January 1, 2021 and June 12, 2022. Probability of association with SARS-CoV-2 vaccination was determined by four independent trained reviewers using a modified WHO algorithm. Among 6,928,359 doses administered, 138 deaths occurred within 30 days of vaccination; eight had a high probability (1.15/1,000,000 doses), 15 had intermediate probability (2.38/1,000,000 doses), and 112 had low probability or no association with vaccination. The death rate among those with high probability of relationship to SARS-CoV-2 vaccination was 0.34/100,000 unique vaccine recipients, while death rate among those with either high or intermediate probability of relationship to SARS-CoV-2 vaccination was 0.98/100,000 unique vaccine recipients. In conclusion, deaths attributable to SARS-CoV-2 vaccination are extremely rare and lower than the overall crude mortality rate in Qatar.
format Online
Article
Text
id pubmed-9808756
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-98087562023-01-04 Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar Butt, Adeel A. Guerrero, Mylai D. Canlas, Elenor B. Al-Dwairi, Husni Alimam, Abeir Bakhiet Mohammed Ali Mohamad, Abdur Rehman Ali, Mohammed Thamer Asaad, Nidal Ahmad Alkeldi, Ali Ahmed Sheikh Saleh Mohammad, Mohammad Fawaz Saber Thomas, Anil G. Al-Khal, Abdullatif Al-Maslamani, Muna Abou-Samra, Abdul-Badi Nat Commun Article Accurate determination of mortality attributable to SARS-CoV-2 vaccination is critical in allaying concerns about their safety. We reviewed every death in Qatar that occurred within 30 days of any SARS-CoV-2 vaccine administration between January 1, 2021 and June 12, 2022. Probability of association with SARS-CoV-2 vaccination was determined by four independent trained reviewers using a modified WHO algorithm. Among 6,928,359 doses administered, 138 deaths occurred within 30 days of vaccination; eight had a high probability (1.15/1,000,000 doses), 15 had intermediate probability (2.38/1,000,000 doses), and 112 had low probability or no association with vaccination. The death rate among those with high probability of relationship to SARS-CoV-2 vaccination was 0.34/100,000 unique vaccine recipients, while death rate among those with either high or intermediate probability of relationship to SARS-CoV-2 vaccination was 0.98/100,000 unique vaccine recipients. In conclusion, deaths attributable to SARS-CoV-2 vaccination are extremely rare and lower than the overall crude mortality rate in Qatar. Nature Publishing Group UK 2023-01-03 /pmc/articles/PMC9808756/ /pubmed/36596793 http://dx.doi.org/10.1038/s41467-022-35653-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Butt, Adeel A.
Guerrero, Mylai D.
Canlas, Elenor B.
Al-Dwairi, Husni
Alimam, Abeir Bakhiet Mohammed Ali
Mohamad, Abdur Rehman
Ali, Mohammed Thamer
Asaad, Nidal Ahmad
Alkeldi, Ali Ahmed Sheikh Saleh
Mohammad, Mohammad Fawaz Saber
Thomas, Anil G.
Al-Khal, Abdullatif
Al-Maslamani, Muna
Abou-Samra, Abdul-Badi
Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar
title Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar
title_full Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar
title_fullStr Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar
title_full_unstemmed Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar
title_short Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar
title_sort evaluation of mortality attributable to sars-cov-2 vaccine administration using national level data from qatar
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808756/
https://www.ncbi.nlm.nih.gov/pubmed/36596793
http://dx.doi.org/10.1038/s41467-022-35653-z
work_keys_str_mv AT buttadeela evaluationofmortalityattributabletosarscov2vaccineadministrationusingnationalleveldatafromqatar
AT guerreromylaid evaluationofmortalityattributabletosarscov2vaccineadministrationusingnationalleveldatafromqatar
AT canlaselenorb evaluationofmortalityattributabletosarscov2vaccineadministrationusingnationalleveldatafromqatar
AT aldwairihusni evaluationofmortalityattributabletosarscov2vaccineadministrationusingnationalleveldatafromqatar
AT alimamabeirbakhietmohammedali evaluationofmortalityattributabletosarscov2vaccineadministrationusingnationalleveldatafromqatar
AT mohamadabdurrehman evaluationofmortalityattributabletosarscov2vaccineadministrationusingnationalleveldatafromqatar
AT alimohammedthamer evaluationofmortalityattributabletosarscov2vaccineadministrationusingnationalleveldatafromqatar
AT asaadnidalahmad evaluationofmortalityattributabletosarscov2vaccineadministrationusingnationalleveldatafromqatar
AT alkeldialiahmedsheikhsaleh evaluationofmortalityattributabletosarscov2vaccineadministrationusingnationalleveldatafromqatar
AT mohammadmohammadfawazsaber evaluationofmortalityattributabletosarscov2vaccineadministrationusingnationalleveldatafromqatar
AT thomasanilg evaluationofmortalityattributabletosarscov2vaccineadministrationusingnationalleveldatafromqatar
AT alkhalabdullatif evaluationofmortalityattributabletosarscov2vaccineadministrationusingnationalleveldatafromqatar
AT almaslamanimuna evaluationofmortalityattributabletosarscov2vaccineadministrationusingnationalleveldatafromqatar
AT abousamraabdulbadi evaluationofmortalityattributabletosarscov2vaccineadministrationusingnationalleveldatafromqatar